2024 - Bispecific Antibody Therapeutics: Challenges and Future Directions
Date2024-06-17
Deadline2024-06-17
VenueONLINE-VIRTUAL, USA - United States
KeywordsLife Sciences; Pharma Manufacturing & Supply Chain; Drug Discovery & Development
Topics/Call fo Papers
Discover an informative webinar that focuses on the diverse architectures of bi-specific antibody (bsAb) therapeutics and highlights the innovative strategies employed for their production.
Bi-specific antibodies (bsAbs) demonstrate novel functionalities that yield remarkable promise in improving the drug therapeutic efficacy through the recognition and targeting of two different antigens or epitopes. Although the optimized purification of mAbs serves as a good starting point for the purification of bsAbs, further optimization is challenging due to the differences in their intrinsic structure.
In this webinar, the expert speaker will provide insights into the various architectures of BsAbs, focusing on strategies for production.
Register for this webinar today to gain insights into the unique challenges and innovative solutions in bispecific antibody therapeutics, their ability to target dual antigens and the diverse architectures that enhance therapeutic efficacy.
Keywords: Antibodies, Drug Development, Antibody, Drug Discovery, Cell Therapy, Biotherapeutics, Monoclonal Antibodies, Monoclonal Antibody, Basic Research, Bispecific Antibody
Bi-specific antibodies (bsAbs) demonstrate novel functionalities that yield remarkable promise in improving the drug therapeutic efficacy through the recognition and targeting of two different antigens or epitopes. Although the optimized purification of mAbs serves as a good starting point for the purification of bsAbs, further optimization is challenging due to the differences in their intrinsic structure.
In this webinar, the expert speaker will provide insights into the various architectures of BsAbs, focusing on strategies for production.
Register for this webinar today to gain insights into the unique challenges and innovative solutions in bispecific antibody therapeutics, their ability to target dual antigens and the diverse architectures that enhance therapeutic efficacy.
Keywords: Antibodies, Drug Development, Antibody, Drug Discovery, Cell Therapy, Biotherapeutics, Monoclonal Antibodies, Monoclonal Antibody, Basic Research, Bispecific Antibody
Other CFPs
- Unlocking precision medicine: An overview of Illumina’s TSO500
- How Can AI-Assisted Image Analysis Boost Productivity in Preclinical Research, Including GLP?
- Using Prognostic AI Models in Pathology: Case Colorectal Cancer
- Advancing Alzheimer’s Clinical Trial Endpoints: Imaging Biomarkers, COA Challenges, Movement Measures, and CV Risk
- Regulatory Documentation: Navigating the Complexities of Documentation Compliance
Last modified: 2024-06-12 05:10:09